Tower Research Capital LLC (TRC) - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 19 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,400
-14.2%
12,334
+18.8%
0.00%
Q2 2023$8,620
+215400.0%
10,385
+0.7%
0.00%
Q1 2023$4
-60.0%
10,316
-54.6%
0.00%
Q4 2022$10
-99.9%
22,728
+38.5%
0.00%
Q3 2022$9,000
-18.2%
16,407
+119.4%
0.00%
Q2 2022$11,000
+450.0%
7,478
+1264.6%
0.00%
Q1 2022$2,000
-71.4%
548
-25.6%
0.00%
Q4 2021$7,000
-92.8%
737
-89.3%
0.00%
-100.0%
Q3 2021$97,0006,8590.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$9,687,0004.74%
Abingworth LLP 4,822,114$6,462,0002.07%
OUP Management Co., LLC 1,025,697$1,456,0002.00%
Column Group LLC 4,309,329$6,119,0001.30%
Evolution Capital Management LLC 527,885$750,0001.12%
SECTORAL ASSET MANAGEMENT INC 2,382,644$3,383,0000.68%
Parallel Advisors, LLC 1,693,559$2,405,0000.11%
RESOLUTE FINANCIAL, LLC 30,000$43,0000.04%
Oasis Management Co Ltd. 100,000$142,0000.02%
Blackstone Inc. 1,308,587$1,858,0000.01%
View complete list of EFFECTOR THERAPEUTICS INC shareholders